Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Hybribio logo — Betterment of Human Health We Care.

Hybribio

Betterment of Human Health We Care.

Founded 2003 China Chaozhou, China 28 employees

General Information

Company Name Hybribio
Founded Year 2003
Location China Chaozhou, China +2
Employees 28
Social

Get notified when Hybribio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Hybribio

Hybribio (Stock code: 300639.SZ) is the leading supplier of nucleic acid molecular diagnostic products, also the largest HPV diagnosis device manufacture in China, with a complete operation chain, from research and development, production, to sales. In 2017, Hybribio was listed in GEM of Shenzhen Stock Exchange. We developed our IVD platform based on patented technology - “Flow-through Hybridization”licensed by The University of Hong Kong，and established two major R&D lines - infectious pathogen detection and genetic disease detection. Our products, which have been approved by CFDA and have obtained CE-IVD, WHO licenses, have been extensively used in medical and research laboratories in European and Asian countries. So far, Hybribio's diagnostic reagents have been exported to over 30 countries. Taking advantage of the accumulated experience in the past 16 years, shortly after the outbreak of COVID-19, Hybribio has successfully developed COVID-19 nucleic acid detection kit, to assist medical institutions and disease control departments to take timely and effective prevention and control measures, as one of the accredited product and service provider. On March 4th, our detection kit is also CE-certified by the European Union and WHO EUL qualified by WHO.

No funding data available for Hybribio yet.

Get notified when Hybribio raises funding

Hybribio Alternatives & Competitors

Hybribio vs
Tianlong Science and Technology
Tianlong Science and Technology China

Bring Technology to Life! Let more people see the color of their dreaming life!

51 employees
Hybribio vs
Tetracore Inc
Tetracore Inc United States

Providing Advanced Molecular and Immunological Detection

64 employees
Biotechnology, Health Care
Hybribio vs
Nuclea Biotechnologies
Nuclea Biotechnologies United States

Since our founding in 2005, Nuclea has been focused on the development of IVD and RUO diagnostic ass...

Series Unknown
18 employees
Biotechnology, Health Care

FAQ About Hybribio

Betterment of Human Health We Care.
Hybribio was founded in 2003.
Hybribio is headquartered in Chaozhou, China.
Hybribio has approximately 28 employees.
Top alternatives and competitors to Hybribio include Tianlong Science and Technology, Tetracore Inc, Nuclea Biotechnologies, E&S Healthcare Co., Ltd., Bio Synthesis . These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Hybribio and Tianlong Science and Technology are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Hybribio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy